Supplementary Protection Certificates are a vital tool for extending protection for authorised human and veterinary medicinal products. Yet the SPC landscape remains complex, fast-moving and often difficult to navigate.

Although the SPC Regulation sets out only four core requirements for grant, each has generated significant legal debate and repeated referrals to the CJEU. Recent legal and political developments continue to shape how these requirements are interpreted.

In this webinar, J A Kemp’s experienced SPC attorneys will provide a practical update on the latest developments affecting SPC strategy in Europe and the UK. Drawing on our extensive experience filing and prosecuting SPCs across multiple jurisdictions, we will highlight key issues to consider when preparing and managing patent portfolios to make the most of the SPC system.

The session will focus not only on what has changed, but on what those changes mean in practice for patent drafting, filing strategy, ownership planning and third-party risk.

Topics will include:
Recent legal developments affecting SPC strategy
Optimising a patent portfolio for SPC protection
Choosing the right patent for SPC applications
SPC considerations in the UK after Brexit
Political developments in Europe affecting SPCs
Whether you are managing an existing SPC portfolio or planning future protection for medicinal products in Europe, this webinar will offer practical guidance on responding to a changing legal landscape and strengthening your SPC strategy.